Posts Tagged ‘ICER’

Daily MHAM Headlines for June 14th

Headlines - Your Daily Dose During National Migraine and Headache Awareness Month

 June 14th Featured Content – Healthy Women Should Your Insurance Cover Your Migraine Treatment? _______________________________________________________________________________________________________ Migraine Journeys – MigraineAgain Click on image to read this story and share ________________________________________________________________________________________________________ Miles for Migraine Trivia Which is the least acceptable reason to miss work according to employers? Back pain Flu Asthma Depression Migraine ________________________________________________________________________________ Fact-A-Day – U.S.…

Read More

Daily MHAM Headlines for June 13th

Headlines - Your Daily Dose During National Migraine and Headache Awareness Month

 June 13th Recognition Day Headache Advocacy   Featured Content – MigraineAgain.com These Advocates Are Bringing Migraine out of the Shadows INvisible Project Click image to read and share this story. Michelle Tracy Be Visible – Chronic Migraine Awareness, Inc & Migraine Mantras Click on image to share on social media Fact-A-Day – U.S. Pain Foundation &…

Read More

CHAMP Statement on ICER Evidence Report

CHAMP FB

“We appreciate the attention that ICER’s review has brought to a disease that is often overlooked and undertreated. These new CGRP inhibitors are the first medicines developed and approved for the prevention of migraine attacks. With ICER finding that these medicines are cost-effective for migraine patients that have been failed by other treatments, we call…

Read More

Updated ICER Patient Input Guide

ICER

The voice of migraine patients must be heard!
ICER is evaluating the new CGRP inhibitor medicines and they have refused our request to have a migraine patient or a headache specialist on the voting panel. They must hear from patients via written submissions so that the voting panel understands the pain, disability and burden of migraine disease and the desperate need for access to more effective treatments.

Read More